Search results
Results from the WOW.Com Content Network
MAO-B selective: D-Deprenyl • Selegiline (L-deprenyl) • Ladostigil • Lazabemide • Milacemide • Mofegiline • Pargyline • Rasagiline • Safinamide. Catechol-O-methyl transferase (COMT) inhibitors. Entacapone • Nitecapone • Opicapone • Tolcapone. Dopamine beta hydroxylase inhibitors. Bupicomide • Disulfiram • Dopastin ...
In Wikidata. A dopamine agonist is a compound that activates dopamine receptors. There are two families of dopamine receptors, D 1 -like and D 2 -like. They are all G protein-coupled receptors. D 1 - and D 5 -receptors belong to the D 1 -like family and the D 2 -like family includes D 2, D 3 and D 4 receptors. [ 1 ]
Dopamine (DA, a contraction of 3,4- d ihydr o xy p henethyl amine) is a neuromodulatory molecule that plays several important roles in cells. It is an organic chemical of the catecholamine and phenethylamine families. Dopamine constitutes about 80% of the catecholamine content in the brain.
Legal status. In Wikidata. A dopamine reuptake inhibitor (DRI) is a class of drug which acts as a reuptake inhibitor of the monoamine neurotransmitter dopamine by blocking the action of the dopamine transporter (DAT). Reuptake inhibition is achieved when extracellular dopamine not absorbed by the postsynaptic neuron is blocked from re-entering ...
A dopamine antagonist, also known as an anti-dopaminergic and a dopamine receptor antagonist (DRA), is a type of drug which blocks dopamine receptors by receptor antagonism. Most antipsychotics are dopamine antagonists, and as such they have found use in treating schizophrenia, bipolar disorder, and stimulant psychosis. [ 1 ]
Stimulant. Ritalin: 20 mg sustained-release (SR) tablets. Stimulants (also known as central nervous system stimulants, or psychostimulants, or colloquially as uppers) are a class of drugs that increase the activity of the brain. They are used for various purposes, such as enhancing alertness, attention, motivation, cognition, mood, and physical ...
Dopamine replacement therapy (DRT) is an effective treatment for patients with decreased levels of dopamine. Often dopamine antagonists, compounds that activate dopamine receptors in the absence of that receptor's physiological ligand, the neurotransmitter dopamine, are used in this therapy. DRT has been shown to reduce symptoms and increase ...
Antipsychotic drugs such as haloperidol and chlorpromazine tend to block dopamine D 2 receptors in the dopaminergic pathways of the brain. This means that dopamine released in these pathways has less effect. Excess release of dopamine in the mesolimbic pathway has been linked to psychotic experiences. Decreased dopamine release in the ...